Tirzepatide Week 1: What to Expect, Weight Loss & Tips
Tirzepatide week 1 guide covering expected weight loss, side effects at the 2.5 mg dose, diet and exercise tips, and how your results compare to SURMOUNT trial data.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. This guide provides week-specific information for patients on tirzepatide therapy. Content is updated regularly to reflect the latest clinical evidence and patient outcomes.
Quick links: Tirzepatide treatment, semaglutide treatment, and tirzepatide weight loss results.
More on Tirzepatide Timeline
Tirzepatide Week 2
What to expect during week 2 of tirzepatide treatment.
Tirzepatide Weight Loss Results
Complete overview of tirzepatide weight loss results from clinical trials and real patients.
How Much Weight Can You Lose on Tirzepatide
Realistic expectations for total weight loss on tirzepatide at each dose level.
What Happens During Week 1 of Tirzepatide?
Week 1 is your very first injection. Most patients administer tirzepatide subcutaneously in the abdomen, thigh, or upper arm. You may feel anxious about the first injection, but the needle is thin and the process is quick. In the first 48 to 72 hours, you may notice a subtle decrease in appetite and occasional mild nausea. Some patients feel nothing at all during the first week, which is completely normal as the medication builds in your system. Focus on staying hydrated with at least 64 ounces of water daily and eating regular, balanced meals.
At the 2.5 mg dose during the starting dose, tirzepatide is beginning to activate your GLP-1 and GIP receptors, initiating the dual hormone signaling that makes this medication unique among weight loss treatments. The medication works by mimicking both the GLP-1 and GIP hormones naturally produced in your gut, reducing hunger, slowing gastric emptying, and improving how your body processes glucose and stores fat.
If you are looking for information about week 2, visit that guide for week-specific details. For a complete overview of what tirzepatide can achieve, see our guide on how much weight you can lose on tirzepatide.
Expected Weight Loss at Week 1
By week 1 of tirzepatide treatment at the 2.5 mg dose, patients typically experience cumulative weight loss of 3-5 lbs. This represents approximately 1-2% of starting body weight for most patients, though individual results can vary significantly based on factors including starting weight, metabolic rate, dietary adherence, physical activity level, and genetic factors that influence how your body responds to GLP-1 receptor agonist therapy.
In the SURMOUNT-1 clinical trial, patients in the early weeks of treatment at the 2.5 mg starting dose began showing measurable weight reduction even before dose escalation. The trial demonstrated that tirzepatide produces meaningful results from the very first month, with the dual GLP-1 and GIP mechanism providing appetite suppression that patients notice within the first one to two weeks.
Week 1 Weight Loss Snapshot
Dose: 2.5 mg | Typical cumulative loss: 3-5 lbs | Body weight reduction: 1-2% | Phase: Starting Dose
For context on how these results compare to other GLP-1 medications, see our detailed tirzepatide vs semaglutide comparison. Tirzepatide consistently outperforms semaglutide in clinical trials due to its dual mechanism of action, and this advantage is evident even at week 1 of treatment.
Side Effects at Week 1
Most patients at the 2.5 mg starting dose experience only mild side effects. Nausea tends to be the most common complaint, typically occurring within the first few days after injection and subsiding within 24 to 48 hours. Some patients report mild bloating, reduced appetite that feels unfamiliar, and occasional loose stools. These effects are generally manageable and indicate the medication is beginning to work on your GLP-1 and GIP receptors.
Nausea: Common and typically most pronounced in the first 2-3 days after injection or dose increase
Appetite suppression: Noticeable but mild, becoming your first sign that the medication is working
Gastrointestinal changes: Constipation, diarrhea, or bloating may occur as your digestive system adjusts to slowed gastric emptying
Injection site reactions: Mild redness or slight discomfort at the injection site that typically resolves within a day
Headache: Some patients experience mild headaches, especially during dose increases, that respond to over-the-counter pain relievers
For a comprehensive overview of all potential side effects, read our complete guide on tirzepatide side effects. If you experience severe or persistent symptoms, contact your healthcare provider promptly.
Appetite and Food Changes at Week 1
Your first noticeable appetite suppression is likely beginning. Many patients describe feeling satisfied with smaller portions, noticing reduced cravings for high-calorie snacks, and finding it easier to skip unnecessary eating. This is the dual GLP-1 and GIP action starting to modulate your hunger hormones.
Understanding how tirzepatide affects your appetite is key to maximizing your results. Unlike stimulant-based weight loss medications that create jittery energy, tirzepatide works through your body's natural hormone signaling pathways. The GLP-1 receptor activation slows gastric emptying, making you feel fuller longer after meals, while the GIP receptor activation improves your body's ability to process nutrients efficiently. Together, these mechanisms create a sustainable reduction in caloric intake without the feeling of deprivation that characterizes most diets.
At week 1, many patients describe the reduction in food noise — that persistent mental chatter about what to eat, when to eat, and how much to eat — as beginning to quiet down, with noticeably fewer intrusive food thoughts throughout the day. This psychological benefit is often cited as one of the most transformative aspects of GLP-1 therapy.
Diet Tips for Week 1
Focus on establishing a protein-rich eating pattern now. Aim for 25 to 30 grams of protein per meal to preserve lean muscle mass as you begin losing weight. Choose lean proteins like chicken, fish, eggs, and Greek yogurt. Eat slowly and stop when you feel comfortably satisfied rather than full.
Prioritize protein at every meal — aim for at least 25 grams per meal to preserve lean muscle mass during weight loss
Eat slowly and mindfully, taking at least 20 minutes per meal to allow your brain to register fullness signals
Stay hydrated with at least 64 ounces of water daily, sipping throughout the day rather than drinking large amounts at once
Avoid high-fat fried foods and heavy sauces that can worsen nausea and gastrointestinal side effects
Include fiber-rich vegetables and whole grains to support digestive health and maintain regular bowel movements
Plan meals in advance to ensure you are eating nutritious foods even when appetite is low
For a deeper look at the complete GLP-1 treatment guide, including nutritional strategies optimized for patients on tirzepatide and semaglutide, visit our comprehensive resource. Proper nutrition significantly impacts both the rate and sustainability of your weight loss results.
Exercise Recommendations for Week 1
Start with gentle daily walks of 20 to 30 minutes. Your body is adjusting to the medication, so avoid intense exercise that might worsen nausea. Light stretching and yoga can help with any bloating or digestive discomfort.
Physical activity during week 1 of tirzepatide treatment serves multiple purposes beyond accelerating weight loss. Regular exercise helps preserve lean muscle mass, which is critical during any period of significant weight reduction. Muscle preservation maintains your metabolic rate, improves body composition, and ensures that the weight you lose is predominantly fat rather than muscle tissue. Additionally, exercise improves cardiovascular health, enhances insulin sensitivity, boosts mood through endorphin release, and supports better sleep quality.
During these early weeks, listen to your body carefully. Some patients feel mildly nauseous after exercise, particularly on injection days. If this occurs, try scheduling your workouts for the day before your injection or two to three days after, when medication-related nausea is typically at its lowest.
SURMOUNT Trial Data: Week 1 Context
In the SURMOUNT-1 clinical trial, patients in the early weeks of treatment at the 2.5 mg starting dose began showing measurable weight reduction even before dose escalation. The trial demonstrated that tirzepatide produces meaningful results from the very first month, with the dual GLP-1 and GIP mechanism providing appetite suppression that patients notice within the first one to two weeks.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity or overweight with at least one weight-related comorbidity. Participants were randomized to receive tirzepatide at 5 mg, 10 mg, or 15 mg, or placebo. The trial ran for 72 weeks and demonstrated that all tirzepatide dose groups achieved statistically significant and clinically meaningful weight loss compared to placebo. The results established tirzepatide as the most effective GLP-1 based weight loss medication in clinical use.
At week 1, your results should be evaluated in the context of these clinical benchmarks. If your weight loss is tracking at or above the trial averages, you are responding well to treatment. If your results are below expectations, discuss with your provider whether dose adjustment, dietary modifications, or additional interventions might help optimize your outcome. For detailed tirzepatide weight loss results across all dose levels, see our comprehensive analysis.
Getting Tirzepatide at $125 Per Month
One of the biggest barriers to tirzepatide therapy is cost. Brand-name Zepbound and Mounjaro can cost over $1,000 per month without insurance. Trimi offers compounded tirzepatide starting at $125 per month, making this life-changing medication accessible to patients who might otherwise be unable to afford treatment.
Trimi's pricing includes the medication, provider consultations, ongoing medical oversight, and free shipping — no hidden fees, no consultation charges, and no long-term contracts. You can start, adjust, or cancel your treatment at any time. Every prescription is evaluated by board-certified providers who specialize in weight management and metabolic health, ensuring you receive expert guidance throughout your treatment journey.
For patients at week 1 who are considering starting treatment or switching providers, Trimi offers a straightforward path to affordable tirzepatide therapy. Visit our best GLP-1 provider guide to compare your options and find the right fit for your weight loss goals.
Tips for Success at Week 1
Be patient with the starting dose — results accelerate as your dose increases over the coming weeks
Track your progress with weekly weigh-ins taken at the same time under the same conditions for accuracy
Take progress photos monthly — the mirror and scale do not always reflect the full extent of your transformation
Communicate openly with your provider about any side effects, concerns, or questions about your treatment plan
Connect with a community of other tirzepatide patients for support, motivation, and shared experience
Keep a food journal to identify patterns in what triggers nausea and what foods you tolerate well
Get adequate sleep of 7 to 9 hours per night, which supports both weight loss and overall recovery
Frequently Asked Questions
How much weight should I lose by week 1 of tirzepatide?
By week 1 of tirzepatide treatment at the 2.5 mg dose, most patients have lost approximately 3-5 lbs from their starting weight, which typically represents 1-2% of total body weight. Individual results vary based on starting weight, diet, exercise, and metabolic factors. The SURMOUNT clinical trials showed consistent weight loss at this stage of treatment, though some patients may lose more or less than the average.
What are the common side effects at week 1 on tirzepatide?
At week 1 on the 2.5 mg dose, common side effects include mild gastrointestinal effects such as nausea, mild bloating, and occasional constipation. Most patients find that side effects are mild and manageable at this starting dose. If you experience severe or persistent side effects, contact your healthcare provider for guidance on managing symptoms or adjusting your treatment plan.
Should I increase my tirzepatide dose after week 1?
Dose escalation decisions at week 1 should be made in consultation with your healthcare provider based on your individual response, side effect tolerance, and weight loss goals. Most patients move from 2.5 mg to 5 mg after 4 weeks if the starting dose is well-tolerated. Never adjust your dose without medical guidance.
What should I eat during week 1 of tirzepatide?
During week 1 on tirzepatide, your nutritional strategy should emphasize quality and consistency. Focus on establishing a protein-rich eating pattern now. Aim for 25 to 30 grams of protein per meal to preserve lean muscle mass as you begin losing weight. Choose lean proteins like chicken, fish, eggs, and Greek yogurt. Eat slowly and stop when you feel comfortably satisfied rather than full. The reduced appetite caused by tirzepatide means every calorie counts more, so prioritize nutrient-dense whole foods including lean proteins, vegetables, fruits, and whole grains. Avoid high-fat and high-sugar processed foods which can worsen gastrointestinal side effects. Stay well-hydrated with at least 64 ounces of water daily, as proper hydration supports both weight loss and side effect management.
Is it normal to hit a weight loss plateau at week 1?
Weight loss plateaus in the first 8 weeks are relatively uncommon since the medication is still building in your system and your body is adjusting to the initial caloric deficit. If your weight stalls briefly, continue your routine and it should resume within a few days.
Can I exercise during week 1 of tirzepatide treatment?
Absolutely. Exercise during week 1 of tirzepatide is encouraged and enhances your results. Start with gentle daily walks of 20 to 30 minutes. Your body is adjusting to the medication, so avoid intense exercise that might worsen nausea. Light stretching and yoga can help with any bloating or digestive discomfort. Listen to your body and adjust intensity based on how you feel, especially on injection days when nausea may be more noticeable. Regular physical activity not only accelerates weight loss but also helps preserve lean muscle mass, improves cardiovascular health, boosts mood, and supports long-term weight maintenance after treatment.
How does week 1 on tirzepatide compare to semaglutide?
At week 1, tirzepatide typically produces greater weight loss than semaglutide at a comparable timepoint. Clinical trial data from the SURMOUNT trials for tirzepatide and the STEP trials for semaglutide show that tirzepatide patients lose approximately 20 to 25 percent more total body weight on average. This advantage comes from tirzepatide's dual mechanism of action, targeting both GLP-1 and GIP receptors, compared to semaglutide which targets only GLP-1. However, individual responses vary and some patients may respond better to one medication over the other.
Sources & References
- SURMOUNT-1 trial: tirzepatide once weekly for the treatment of obesity (New England Journal of Medicine, 2022).
- SURMOUNT-2 trial: tirzepatide for treatment of obesity in people with type 2 diabetes (PubMed).
- Zepbound (tirzepatide) prescribing information from the FDA.
- STEP 1 trial: semaglutide in adults with overweight or obesity for comparison context (PubMed).
- NIDDK overview of prescription medications for overweight and obesity.
- FDA guidance on drug compounding and the FDA.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual results vary significantly based on starting weight, metabolic factors, diet, exercise, and medication adherence. Always consult a qualified healthcare provider before starting, adjusting, or discontinuing any medication. The weight loss figures cited are based on clinical trial averages and may not reflect your individual experience. Trimi provides compounded tirzepatide — this is not a review of brand-name Zepbound or Mounjaro.